SKN | Attovia Therapeutics, Inc. Common Stock: Biotechnology IPO Draws Investor Focus as Company Advances Clinical Pipeline
Attovia Therapeutics, Inc. is preparing for its public market debut as investors evaluate the growth potential of a biotechnology company focused on developing next-generation...
SKN | ARC Group Securities Acquisition I Raises $105 Million in SPAC IPO Led by ARC Group Executives
ARC Group Securities Acquisition I has successfully completed its initial public offering (IPO), raising $105 million through the sale of 10.5 million units priced...
SKN | Phalanx Acquisition Corp I Units IPO Seeks to Capitalize on Selective SPAC Market Recovery
Phalanx Acquisition Corp I Units is preparing for its initial public offering (IPO), aiming to raise capital through a special purpose acquisition company (SPAC)...
SKN | Tidal Trust II Expands Investment Platform with New Fund Market Debut
Tidal Trust II is preparing to introduce a new investment product to the public markets, reflecting continued demand for innovative fund structures and specialized...
SKN | East West Ave Acquisition Raises $100 Million IPO to Target Fintech, Digital Assets, and Energy Solutions
Special purpose acquisition company (SPAC) East West Ave Acquisition has successfully priced its $100 million initial public offering, positioning itself to pursue merger opportunities...